Therefore, new therapeutic strategy will hopefully be developed by targeting on proNGF-p75NTR-sortilin signaling in aberrant activated microglias for treatment of various neurodegenerative diseases in human beings. This evidence concerns the gene SORT1 and neurodegenerative disease.